The primary purpose of this funding opportunity announcement (FOA) is to support and facilitate multidisciplinary approaches towards the development of new and/or improved contraceptive methods for both men and women through the formation of a Contraceptive Research Development Center. This FOA also allows the inclusion of translational studies to facilitate the pre-clinical to clinical transition and increase the likelihood of clinical success. Additionally, it allows for behavioral/social science, including market research to test user acceptability, research projects that are responding and well-coordinated to the contraceptive product being developed. The Center will serve as a national resource for development of early stage investigators electing to pursue careers in contraceptive research.
Deadlines:
- Letter of Intent Due Date(s): 30 days prior to the application due date
- Application Due Date(s): November 29, 2021
RFA-HD-22-003 Expiration Date New Date November 30, 2021 per issuance of NOT-HD-20-044. (Original Expiration Date: March 31, 2021 )